According to the research report, the global bioanalytical testing services market size is expected to touch USD 10.39 Billion by 2032, from USD 4.38 Billion in 2022, growing with a significant CAGR of 9.02% from 2023 to 2032.
Key Takeaways:
- North America generated more than 47% of revenue share in 2022.
- By Test Type, the bioavailability segment contributed to the largest revenue share in 2022.
- By Application, the oncology segment is expected to expand at the fastest CAGR between 2023 and 2032.
The bioanalytical testing services report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global bioanalytical testing services in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global bioanalytical testing services market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global bioanalytical testing services during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3107
This study covers a detailed segmentation of the global bioanalytical testing services market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global bioanalytical testing services market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- PPD, Inc.
- ICON Plc
- Charles River Laboratories International
- Covance, Inc.
- IQVIA
- Syneos Health
- SGS SA
- Toxikon
- Intertek Group Plc
- Pace Analytical Services LLC
Market Segmentation
By Test Type
- Pharmacokinetic
- Pharmacodynamics
- Bioavailability
- Bioequivalence
By Molecules
- Small Molecules
- Large Molecules
By Application
- Cardiology
- Gastroenterology
- Neurology
- Oncology
- Others
By End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Development and Manufacturing Organizations
- Contract Research Organizations
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global bioanalytical testing services report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global bioanalytical testing services market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bioanalytical Testing Services Market
5.1. COVID-19 Landscape: Bioanalytical Testing Services Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bioanalytical Testing Services Market, By Test Type
8.1. Bioanalytical Testing Services Market, by Test Type, 2023-2032
8.1.1. Pharmacokinetic
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Pharmacodynamics
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Bioavailability
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Bioequivalence
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Bioanalytical Testing Services Market, By Molecules
9.1. Bioanalytical Testing Services Market, by Molecules, 2023-2032
9.1.1. Small Molecules
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Large Molecules
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Bioanalytical Testing Services Market, By Application
10.1. Bioanalytical Testing Services Market, by Application, 2023-2032
10.1.1. Cardiology
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Gastroenterology
10.1.2.1. Market Revenue and Forecast (2020-2032)
10.1.3. Neurology
10.1.3.1. Market Revenue and Forecast (2020-2032)
10.1.4. Oncology
10.1.4.1. Market Revenue and Forecast (2020-2032)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 11. Global Bioanalytical Testing Services Market, By End User
11.1. Bioanalytical Testing Services Market, by End User, 2023-2032
11.1.1. Pharmaceutical and Biopharmaceutical Companies
11.1.1.1. Market Revenue and Forecast (2020-2032)
11.1.2. Contract Development and Manufacturing Organizations
11.1.2.1. Market Revenue and Forecast (2020-2032)
11.1.3. Contract Research Organizations
11.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 12. Global Bioanalytical Testing Services Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.1.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.1.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.2.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.2.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.3.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.3.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.7.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.7.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.4.8.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.4.8.3. Market Revenue and Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.5.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.5.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Test Type (2020-2032)
12.5.6.2. Market Revenue and Forecast, by Molecules (2020-2032)
12.5.6.3. Market Revenue and Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. PPD, Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. ICON Plc
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Charles River Laboratories International
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Covance, Inc.
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. IQVIA
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Syneos Health
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. SGS SA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Toxikon
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Intertek Group Plc
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Pace Analytical Services LLC
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments